Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Clinical trial NCT00398125 · COMPLETED

Trial details

NCT number: NCT00398125
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus HIV-1 Infection

Start date: 2006-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.